We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
Cap. Flow
-$1.78B
Cap. Flow %
-1.61%
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46M
2
PLTR icon
Palantir
PLTR
+$40.3M
3
SW
Smurfit Westrock
SW
+$39.2M
4
DELL icon
Dell
DELL
+$29.2M
5
AVTR icon
Avantor
AVTR
+$27.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$97.8M
2
LLY icon
Eli Lilly
LLY
+$58.2M
3
NVDA icon
NVIDIA
NVDA
+$48.6M
4
XOM icon
ExxonMobil
XOM
+$31.3M
5
BAC icon
Bank of America
BAC
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 30.19%
2 Financials 12.91%
3 Healthcare 11.38%
4 Consumer Discretionary 10.81%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKFG
3601
DELISTED
Markforged Holding Corporation
MKFG
$2.45K ﹤0.01%
513
CDT icon
3602
CDT Equity Inc
CDT
$2.16M
0
BPYPM
3603
Brookfield Property Partners 6.25% Class A Cumulative Redeemable Preferred Units Series 1
BPYPM
$2.14K ﹤0.01%
125
NUTX
3604
Nutex Health
NUTX
$1.11B
$2.1K ﹤0.01%
97
-1
-1% -$14
NVNO
3605
enVVeno Medical
NVNO
$7.08M
$2.1K ﹤0.01%
+18
New +$3.31K
QH
3606
Quhuo Limited Class A Ordinary Shares
QH
$12M
$2.06K ﹤0.01%
19
XIN
3607
DELISTED
Xinyuan Real Estate
XIN
$2.05K ﹤0.01%
470
GP
3608
GreenPower Motor Co
GP
$11M
$2.05K ﹤0.01%
150
AIXI
3609
Xiao-I
AIXI
$1.03M
$2.02K ﹤0.01%
18
TRIB
3610
Trinity Biotech
TRIB
$8.39M
$1.99K ﹤0.01%
60
+48
+400% +$3.24K
BNR
3611
Burning Rock Biotech
BNR
$92.9M
$1.9K ﹤0.01%
580
ELA icon
3612
Envela
ELA
$446M
$1.78K ﹤0.01%
325
-1,463
-82% -$7.37K
YDKG
3613
Yueda Digital Holding
YDKG
$5.97M
$1.75K ﹤0.01%
53
BIRD icon
3614
Smartbird Inc
BIRD
$22.3M
$1.72K ﹤0.01%
146
-1,375
-90% -$17.4K
BNTC icon
3615
Benitec Biopharma
BNTC
$468M
$1.71K ﹤0.01%
186
BDRX
3616
Biodexa Pharmaceuticals
BDRX
$1.58M
$1.7K ﹤0.01%
5
+3
+150% +$2.3K
NBP
3617
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$1.69K ﹤0.01%
1,367
SLAI
3618
DELISTED
SOLAI Ltd ADS
SLAI
$1.69K ﹤0.01%
103
NCTY
3619
The9 Ltd
NCTY
$71.9M
$1.66K ﹤0.01%
247
LEJU
3620
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$1.66K ﹤0.01%
6,410
CMTL icon
3621
Comtech Telecommunications
CMTL
$51.8M
$1.54K ﹤0.01%
320
-14,818
-98% -$48.6K
XYLO
3622
DELISTED
Xylo Technologies
XYLO
$1.52K ﹤0.01%
473
-1
-0.2% -$4
PDLI
3623
DELISTED
PDL BioPharma, Inc.
PDLI
$1.51K ﹤0.01%
612
CIAN
3624
DELISTED
Cian PLC American Depositary Shares, each representing one Ordinary Share
CIAN
$1.46K ﹤0.01%
430
ATRA icon
3625
Atara Biotherapeutics
ATRA
$76.1M
$1.42K ﹤0.01%
175
-507
-74% -$4.34K

Similar funds

RhumbLine Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
  • RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
  • RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
  • RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
  • RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
  • RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
  • RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.